Hexo Corp Falls Out Of Listing Compliance With Nasdaq, Has 180 Days To Correct Issue

As was expected by many followers of the Canadian cannabis space, it appears that Hexo Corp (TSX: HEXO) is facing some trouble with its US listing. The firm has fallen out of compliance as a result of its share price not meeting listing requirements.

The firm has seen its equity trade below US$1.00 for a period of 30 days, resulting in it no longer meeting compliance standards for the Nasdaq markets. The company now has 180 days, or until July 25, 2022, to meeting the listing requirement.

While the company has indicated it just needs to trade above $1.00 for a period of 10 consecutive trading days, the firm this morning in making the announcement did not provide a path to regaining compliance. The most common method of regaining such compliance, which it has been required to do in the past, is by conducting a share consolidation, also known as a reverse split. Hexo previously conducted a 4 to 1 share consolidation at the end of December 2020 to meet similar requirements for the NYSE, where it was listed at the time.

It is unclear at this time how the firm intends to regain compliance.

Hexo Corp last traded at $0.65 on the TSX.


Information for this briefing was found via Sedar and Hexo Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The $30,000 Gold Case Just Got Stronger | Simon Marcotte

Why Silver’s Move Is ‘Scary’ to Some Miners | Frank Basa

Are Commodities Entering a Generational Cycle? | Terry Lynch

Recommended

Steadright Closes Out Financing, Raising $1.6 Million For Moroccan Strategy

Questcorp and Riverside Lock Down Key Sonora Mineral Concessions

Related News

Hexo: Canaccord Cuts Price Target In Half To $1.00

On December 14th, Hexo Corp (TSX: HEXO) reported its fiscal first quarter 2022 results. The...

Saturday, December 18, 2021, 01:23:00 PM

Hexo Has Filed A $35 Million Counterclaim Against Medipharm Labs

It appears that Hexo Corp (TSX: HEXO) (NYSE: HEXO) has filed a counterclaim against Medipharm...

Thursday, June 18, 2020, 11:48:39 AM

Tilray Looks To Buy US$211 Million In Hexo Debt, Enter Strategic Alliance

In a sign that the Canadian cannabis operators continue to struggle, especially in terms of...

Thursday, March 3, 2022, 07:37:18 AM

Cantor Releases Industry Report For Cannabis, Aphria Remains Top Pick

Recently, Cantor Fitzgerald released their monthly review of Hifyre data for the four weeks ending...

Sunday, October 4, 2020, 01:57:00 PM

A Look at the Combined Newstrike Brands and Hexo Corp

Newstrike Brands (TSXV: HIP) posted it’s FY18 financial figures yesterday, giving us some insight into...

Wednesday, March 27, 2019, 10:00:41 AM